Sponsorship and Exhibition Opportunities available for the AI in Drug Discovery Conference

Sponsorship and advertising packages are available for the 4th Annual AI in Drug Discovery Conference in London.
By: SAE Media Group
LONDON - Jan. 16, 2023 - PRLog -- With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through the use of machine and deep learning. The current challenges within the drug discovery industry include the significant time consumption and expenses involved. This conference will discuss the solutions to these problems with presentations and updates from leading industry experts.

AI in drug discovery is leading the way into a shorter, cheaper and more successful R&D era where compound generation is automated, drug synthesis is predictable and undruggable diseases are finally being targeted.

The conference will take place on 13 – 14 March 2023, in London, UK.

Visit the website at http://www.ai-indrugdiscovery.com/PR3  to download the brochure and view the full programme

SAE Media Group offers sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement every company's marketing strategy.

Benefits of sponsoring:
  • Networking opportunities
  • Enhance and expand the client base
  • Gain brand awareness
  • Showcase services or products
  • Gain prospect data
  • Drive sales

Join the increasing number of companies benefiting from sponsoring the AI in Drug Discovery Conference.

For more information about the packages please contact please contact Andrew Gibbons on +44 (0) 20 7827 6156 or andrew.gibbons@saemediagroup.com

For delegate enquiries, please contact Oliver Kaye on +44 (0) 20 7827 6017 or


4th Annual AI in Drug Discovery Conference

13 – 14 March 2023

London, UK



Hannah Blake
Source:SAE Media Group
Tags:AI in drug discovery
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Most Viewed
Daily News

Like PRLog?
Click to Share